Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
| Item number | Size | Datasheet | Manual | SDS | Delivery time | Quantity | Price |
|---|---|---|---|---|---|---|---|
| E-AN301921L.50 | 50 µl | - |
7 - 16 business days* |
304.00€
|
|||
| E-AN301921L.100 | 100 µl | - |
7 - 16 business days* |
464.00€
|
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Fibrinogen-like protein 1 (FGL1), also known as hepassocin, is a secreted protein mainly... more
Product information "Anti-Recombinant FGL1, clone A637"
Fibrinogen-like protein 1 (FGL1), also known as hepassocin, is a secreted protein mainly expressed in liver and its expression is further enhanced following acute liver injury. FGL1 null mice have multiple metabolic abnormalities and are more prone to develop hepatocellular carcinoma under certain experimental conditions, suggesting FGL1 has diverse functions in vivo. More recently, FGL1 was found to be highly expressed in human cancer cells and function as an inhibitory ligand for LAG3. Blockade of the FGL1-LAG3 interaction stimulates tumor immunity in mouse models. In addition, a high plasma FGL1 level in human cancer patients is associated with a poor prognosis and resistance to anti-PD-1/PD-L1 immunotherapy.
| Keywords: | Anti-FGL1, Anti-HP-041, Anti-Hepassocin, Anti-Fibrinogen-like protein 1, Anti-Liver fibrinogen-related protein 1, Anti-Hepatocyte-derived fibrinogen-related protein 1, Recombinant FGL1 Monoclonal Antibody |
| Supplier: | Elabscience |
| Supplier-Nr: | E-AN301921L |
Properties
| Application: | WB, IHC |
| Antibody Type: | Monoclonal |
| Clone: | A637 |
| Conjugate: | No |
| Host: | Rabbit |
| Species reactivity: | human |
| Immunogen: | Recombinant human FGL1 fragment |
| MW: | 34 kD |
Database Information
| KEGG ID : | K25536 | Matching products |
| UniProt ID : | Q08830 | Matching products |
| Gene ID : | GeneID 2267 | Matching products |
Handling & Safety
| Storage: | -20°C |
| Shipping: | -20°C (International: -20°C) |
| Signal Word: | Warning |
| GHS Hazard Pictograms: |
|
| H Phrases: | H317 |
| P Phrases: | P261, P272, P280, P302+352, P333+313 |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow.
more
You will get a certificate here
Viewed